Zumutor Biologics Raises $7.3 Million to Advance Cancer Immunotherapy Trials in India and US
Bengaluru-based Zumutor Biologics has secured $7.3 million in Series B funding to accelerate clinical trials for its cancer immunotherapies, including initiating global Phase 2 studies…
Read more